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Abstract
Objective: Limiting SFA intake may minimise the risk of CHD. However, such
reduction often leads to increased intake of carbohydrates. We aimed to evaluate
associations and the interplay of carbohydrate and SFA intake on CHD risk.
Design: Prospective cohort study.
Setting: We followed participants in the Hordaland Health Study, Norway from
1997–1999 through 2009. Information on carbohydrate and SFA intake was
obtained from a FFQ and analysed as continuous and categorical (quartiles) var-
iables. Multivariable Cox regression estimated hazard ratios (HR) and 95 % CI.
Theoretical substitution analyses modelled the substitution of carbohydrates with
other nutrients. CHD was defined as fatal or non-fatal CHD (ICD9 codes 410–414
and ICD10 codes I20–I25).
Participants: 2995 men and women, aged 46–49 years.
Results: Adjusting for age, sex, energy intake, physical activity and smoking, SFA
was associated with lower risk (HRQ4 v. Q1 0·44, 95 % CI 0·26, 0·76, Ptrend= 0·002).
For carbohydrates, the opposite pattern was observed (HRQ4 v. Q1 2·10, 95 % CI
1·22, 3·63, Ptrend= 0·003). SFA from cheese was associated with lower CHD risk
(HRQ4 v. Q1 0·44, 95 % CI 0·24, 0·83, Ptrend= 0·006), while there were no associa-
tions between SFA from other food items and CHD. A 5 E% substitution of carbo-
hydrates with total fat, but not SFA, was associated with lower CHD risk (HR 0·75,
95 % CI 0·62, 0·90).
Conclusions: Higher intake of predominantly high glycaemic carbohydrates and
lower intake of SFA, specifically lower intake from cheese, were associated with
higher CHD risk. Substituting carbohydrates with total fat, but not SFA, was asso-






According to Ancel Keys ‘diet-heart’ hypothesis, a habitu-
ally high intake of SFA may increase the risk of CHD due
to increases in serum total cholesterol (TC)(1,2). Mensink
& Katan(3) published a meta-analysis in 1992, including
twenty-seven controlled trials, concluding that the most
favourable lipoprotein profile for CHD was achieved if
SFA were replaced by unsaturated fatty acids, keeping
the intake of total fat unchanged.
The discovery of the additional pathways leading from
diet to CHD has made the ‘diet-heart’ hypothesis more
complex(4). Advice to reduce SFA as a means to prevent
CHDmay have, indirectly, increased the intake of carbohy-
drates(5,6). While carbohydrates have been considered a
basis of a healthy diet, with grain products at the base of
the Food Guide Pyramid(7), a diet rich in added sugars
and refined grains promotes visceral adiposity and reduces
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energy expenditure(8–10), raising concerns of the potential
for increased CHD risk. On the other hand, if dietary carbo-
hydrates are replaced by fat, the postprandial rise in blood
glucose and insulin decreases while glucagon secretion
increases, resulting in lower CHD risk(11–14). However,
among adults with obesity, Hall et al.(15) found that restric-
tion of dietary fat was associated with a slightly larger body
fat loss than restriction of dietary carbohydrates. Also of
twenty-nine diets with different macronutrient composi-
tions tested inmice, only high-fat diets led to overconsump-
tion and weight gain(16). A review indicated that greater
high glycaemic index carbohydrate intake was associated
with a higher risk of CVD compared with SFA intake(17).
Further, recent prospective studies and reviews as well
as meta-analyses have shown inconclusive associations
between self-reported intakes of either SFA or carbohy-
drates and fatal and non-fatal CHD(18–23).
Given the inconsistencies in the literature, the objective
of the current study was to evaluate the associations of
carbohydrate and SFA intakes with incident CHD in a sam-
ple of middle-age community-dwelling Norwegian adults,
where the intake of carbohydrates varied from 21 to
74 energy percentage (E%) with a median intake of 49 E%,
and where the intake of SFA varied from 4 to 25 E% with a
median intake of 13 E%.
Participants and methods
Study population
The current study is a prospective cohort study of partici-
pants in the community-based Hordaland Health Study
(HUSK) (https://husk-en.w.uib.no/). The recruitment was
based on a cohort from 1992 to 1993 (The Hordaland
Homocysteine Study). In 1997–1999, all living cohort mem-
bers born 1950–1951 and residing in the city of Bergen
or the neighbouring suburban municipalities were invited
to participate in HUSK. The baseline examinations for the
current study were conducted during 1997–1999 as a
collaboration between the National Health Screening
Service (now The Norwegian Institute of Public Health),
The University of Bergen and local health services.
The participation rate was 77 %. Participants underwent
a brief health examination and provided a non-fasting
blood sample. Information on lifestyle was collected
via self-administered questionnaires. A semi-quantitative
FFQwas completed by 87 % of the participants. A total of
3107 participants aged 46–49 years who answered the
FFQ were eligible to be included in the current study.
We excluded twenty-two men and five women who
reported prior CHD, and four men and nineteen women
due to missing information. Further, we excluded twenty-
seven men and thirty-five women who reported extreme
energy intakes (below the 1st percentile: <4707·8 kJ
for men and 2951·8 kJ for women; or above the 99th
percentile: >18907·9 kJ for men and >14944·0 kJ for
women). The final study population thus included 2995
participants.
Dietary assessment
Information on food intake was obtained at baseline
(1997–1999) using a 169-item past-year semi-quantitative
FFQ, a slightly modified version of a previously described
FFQ(24). The validity study of the previous version of the
FFQ in a younger population found that the Spearman cor-
relation coefficients between intake of SFA and carbohy-
drates estimated by the FFQ v. weighed food records
were 0·44 and 0·57, respectively(24). The FFQ was handed
out on the day of the health examination, filled out at home
and returned bymail to theHUSK project centre. It includes
frequency alternatives (fromonce amonth to several times/
d), the number of units eaten and portion sizes (e.g., slices,
glasses and spoons) to capture the habitual diet during the
past year. The information is presented as individual food
or beverage items, food groups and nutrients. Daily
nutrient intakes were computed from a database and soft-
ware system developed at the Department of Nutrition,
University of Oslo (KBS, version 3 . 2). The nutrient data-
base is primarily based on the official Norwegian food
composition table(25). During dietary data collection in
1997–1999, margarine was undergoing rapid composi-
tional changes where large amounts of trans-fatty acids,
an important contributor to unsaturated fat(5,26), were
being reduced due to legislation in Norway(26). Further,
prospectively, there were other changes to unsaturated
fat sources(5); thus, unsaturated fat was not evaluated
as a primary dietary exposure in the current study.
Measurements used as independent variables in the cur-
rent study are the total dietary amount of SFA and carbohy-
drates, as well as intake of SFA and carbohydrates from
different food items. All are expressed as E%.
Health examination and health habits
Baseline examinations included measurements of height,
weight, waist circumference, blood pressure and non-
fasting blood samples. After at least 2 min seated rest, sys-
tolic blood pressure and diastolic blood pressure were
measured three times (Dinamap 845 XT equipment
(Criticon)). Serum samples of TC, HDL-cholesterol, TAG
and glucose were analysed within 7 d at the Department
of Clinical Chemistry, Ullevål University Hospital, Oslo,
using enzymatic methods with reagents from Boehringer
Mannheim (Roche). The Friedewald equation was used
for the calculation of LDL-cholesterol. Information on edu-
cational level and medication use was self-reported.
Hypertension was considered present if the mean
of at least two consecutive measurements of systolic
blood pressure was ≥140 mmHg or diastolic blood
pressure ≥ 90 mmHg or if the use of medication for
hypertension was self-reported.
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Participants taking diabetes medications or reported
having been diagnosed with diabetes were defined as
having diabetes. Also, participants with a serum glucose
level >7 mmol/l who had not eaten a meal during the last
8 h, or with a glucose level >11·1 mmol/l and <8 h since
their last meal, were defined as having diabetes. Pre-diabetes
was defined as having glucose levels between 5·6 and
7 mmol/l at least 8 h after their last meal or between
7·8 and 11 mmol/l <8 h after their last meal.
Participants answered one question on past-year
vigorous physical activity resulting in sweating or shortness
of breath (none, <1, 1–2 or ≥3 h/week). This variable was
treated as a categorical variable with none as the reference.
Participants were classified as either non-smokers,
former smokers or current smokers with non-smokers
as the reference.
Outcome
The study endpoints were incident (first time) hospitalisa-
tion with CHD (ICD9 codes 410–414 and ICD10 codes
I20–I25) as primary or secondary diagnosis or death with
CHD as the underlying cause of death. Participants
were followed from baseline through 31 December 2009
for CHD events through the Cardiovascular Disease in
Norway project (CVDNOR, http://www.cvdnor.no)(27,28)
and The Cause of Death Registry. There were 107 non-fatal
and five fatal episodes. Follow-up time was calculated as
time from participation until CHD, death from other causes,
emigration or 31 December ·2009, whichever occurred
first.
Statistical analyses
Descriptive characteristics include numbers with percent-
ages and medians (25th, 75th percentiles) for categorical
and continuous variables, respectively. Spearman’s rank
correlation (rho, ρ) was used to evaluate correlations
between quartiles of carbohydrate intake and SFA intake
with baseline characteristics. In addition, Spearman corre-
lations of intake of carbohydrates with total fat and SFA
were evaluated. To evaluate linear trends in baseline char-
acteristics across quartiles of carbohydrate and SFA intakes
as percentage of total energy intake, we used ordinal
logistic regression for categorical outcome variables, logis-
tic regression for dichotomous outcome variables and lin-
ear regression for continuous outcome variables where
median intake as E% within each quartile group was used
as the independent variable in the analyses. Cox propor-
tional hazard models were used to calculate adjusted haz-
ard ratios (HR) with 95 % CI for CHD associated with
continuous and quartile intake of carbohydrates and SFA.
The included covariates were potential confounders asso-
ciated with the intake of carbohydrates and SFA and with
CHD, which also modified the association of either SFA
or carbohydrate with CHD when included in the
multivariable model. Two primary analyses are presented:
model 1 adjusted for age (continuous (years)), sex and total
energy intake (continuous (kcal/d)); model 2 additionally
adjusted for vigorous physical activity (none v. <1 h/week,
1–2 h/week or ≥3 h/week) with none as the reference and
smoking habits (non-smokers v. previous smokers and
non-smokers v. current smokers). The following additional
confounders were also evaluated, but inclusion of the var-
iables did not materially alter the associations of SFA or
carbohydrates with CHD: family history of myocardial infarc-
tion, educational level and alcohol intake (E%). Further,
carbohydrate analyses also evaluated consistency in results
after adjustment for energy-adjusted fibre from bread, fruit
and vegetables. SFA analyses were further adjusted for
energy-adjusted intake of cholesterol, PUFA and protein.
Supplementary analyses evaluated models adjusted
for age, sex and energy intake (model 1), with additional
adjustments for HDL-cholesterol, LDL-cholesterol, TAG,
glucose, systolic blood pressure, diastolic blood pressure
and BMI (model 2); with additional adjustments for
diabetes/prediabetes, hypertension, family history of myo-
cardial infarction, statins, oral hypoglycaemics (including
metformin) and insulin and anti-hypertensive medications
(model 3) and with additional adjustments for smoking,
physical activity, alcohol consumption in E% and educa-
tion (model 4) (see online supplementary material,
Supplemental Table S1). To test for linear trends across
intake quartiles, median intake as E% within each quar-
tile group was used as the independent variable. We also
evaluated SFA from cheese and SFA when excluding the
contribution from cheese for their associations with inci-
dent CHD. In additional supplementary analyses, we
stratified intake of SFA on smoking habits (see online
supplementary material, Supplemental Table S2) and
we also evaluated associations between carbohydrates
and SFA from other specific food groups and CHD risk
(see online supplementary material, Supplemental
Tables S3 and S4). Missing data were handled with list-
wise deletion.
The proportional hazard assumption was evaluated
using Schoenfeld’s test.
To evaluate the continuous association between expo-
sure and outcome, and assess potential non-linear associ-
ations, smoothed penalised splines were plotted(29).
We used theoretical substitution analyses to model the
substitution of carbohydrates with SFA(30). Variables for the
E% (per 5 E% unit increments) of all macronutrients except
carbohydrates (SFA, monounsaturated fat, PUFA, protein
and alcohol) were included in a Coxmodelwith adjustment
for total energy intake, age, sex, physical activity and smok-
ing habits. The HR for SFA is then interpreted as the change
in estimated risk for each 5 E% unit increase in SFA while
holding all other variables in the model constant but
allowing for concomitant decreases in carbohydrate intake
as all sources of macronutrients sum to 100 % of energy
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intake. The same approach was used to evaluate the theo-
retical substitution of carbohydrates with other macronu-
trients: total fat, protein and PUFA intake per 5 E%
unit increase in a model with other macronutrients except
carbohydrates(30).
Sensitivity analyseswere conductedwherewe excluded
the first 2 years of observation following the baseline
assessment in all of the above analyses.
Statistical analyses were performed using Stata version
15 (StataCorp LP) and R version 3.4.0 (https://www.r-
project.org/), The R Foundation for Statistical Computing.
P-values <0·05 were considered statistically significant.
Results
Characteristics of the study population
At baseline, mean age was 48 (SD 0·7) years, median BMI
was 24·9 (25th, 75th percentiles 22·8, 27·4) kg/m2, 33·5 %
smoked daily, 45·9 % reported at least 1 h vigorous physi-
cal activity per week and 25·3 % had indications of reduced
metabolic health defined as having hypertension, pre-
diabetes or diabetes. Intake of total fat ranged from 14 to
53 E% with a median intake of 33 E%. Intake of total carbo-
hydrates ranged from 21 to 74 E% with a median intake of
49 E%. Less than 1 and 6 % had an intake of carbohydrates
at or below 30 and 40 E%, respectively, while 3 and <1 %
had an intake of carbohydrates at or above 60 and 70 E%,
respectively. Intake of protein ranged from 6 to 30 E% with
a median intake of 16 E%, while intake of SFA ranged from
4 to 25 E%with amedian intake of 13 E%. Less than 1 % had
an intake of SFA at or below 6 E%, while 14 % had an intake
at or above 15 E%.
During a mean 10·8 (SD 1·3) years of follow-up, repre-
senting 32 449 person-years among 2995 participants
(1282men and 1713women), we documented 112 incident
CHD events. Due to missing values (2·1 % for smoking
habits and 3·8 % for physical activity), multivariable-
adjusted analyses included 2820 participants (1224 men
and 1596 women) and 105 CHD events. Sixty participants
died due to other causes during follow-up. When evaluat-
ing Spearman correlations between carbohydrate quartiles
and baseline characteristics, all correlations (ρ) were
between −0·2 and <0·1. However, evaluation of baseline
characteristics by quartiles of carbohydrate intake identi-
fied that the proportion of participants performing at least
1 h vigorous physical activity per week was higher in
higher quartiles, while the proportions of men, daily smok-
ers and participants with glucose intolerance were lower in
higher quartiles (Table 1). Also, waist circumference, serum
levels of TC, LDL-cholesterol and HDL-cholesterol were
lower in higher carbohydrate quartile groups. Intakes of
total fat, protein and alcohol were lower with higher
quartiles of carbohydrate intake. Bread was the major con-
tributor to carbohydrates in this population. While intake
(g/d per 1000 kcal) of bread, sweetened beverages, juice,
and fruit and berries (both fresh and canned/preserved)
was higher with higher quartiles of carbohydrate intake,
there were less noticeable differences for other carbohy-
drate sources across quartiles. Vegetable and fibre intakes
(g/d per 1000 kcal), for example, were similar in the various
carbohydrate intake quartiles (Table 1).
When evaluating Spearman correlations between SFA
quartiles and the baseline characteristics, all rhos (ρ) were
between –0·1 and <0·1. However, the percentage daily
smokers were higher with higher quartiles of SFA intake,
while the percentage of participants who were men,
performed at least 1 h vigorous physical activity per week
or had hypertension was lower with higher quartiles
(Table 2). Also, BMI, waist circumference and TAG levels,
as well as the percentage taking medications for hypercho-
lesterolaemia, were lower with higher SFA quartiles. While
intake of cheese was higher with higher quartiles of SFA
intake, there were less noticeable differences for other
SFA sources across quartiles. Family history of myocardial
infarction did not differ between quartiles of carbohydrate
(Ptrend 0·95) or SFA (Ptrend 0·23) intake as percentage of total
energy.
Associations between intake of carbohydrates and
SFA and incident CHD
Higher intake of carbohydrates was borderline significantly
associated with higher risk of CHD in model 1 (adjusted for
age, sex and energy intake) (HRQ(quartile)4 v. Q1 1·63, 95 % CI
0·96, 2·76, Ptrend= 0·056) (Table 3). This association
became stronger and significant after further adjustment
for smoking habits and physical activity (model 2)
(HRQ4 v. Q1 2·10, 95 % CI 1·22, 3·63, Ptrend = 0·003).
Also, continuous analyses (per 2 E%) showed signifi-
cantly higher risk of CHD with higher intake of carbohy-
drates (HR 1·12, 95 % CI 1·05, 1·20), after adjusting for
age, sex, energy intake, smoking habits and physical
activity. Further adjustments for intermediate factors,
relevant medications and potential confounders did
not materially influence the association (see online sup-
plementary material, Supplemental Table S1).
Plotting the data adjusting for model 2 covariates indi-
cated a linear relationship (Fig. 1(a)).
When examining the association between carbohy-
drates from various food items, we found no associations
with risk of CHD (see online supplementary material,
Supplemental Table S3).
A high intake of SFA was significantly associated with
lower risk of CHD in the model adjusted for age, sex and
energy intake (model 1) (HRQ4 v. Q1 0·53, 95 % CI 0·32,
0·90, Ptrend= 0·013) (Table 3). This association became
stronger after further adjustment for smoking habits and
physical activity (model 2) (HRQ4 v. Q1 0·44, 95 % CI
0·26, 0·76, Ptrend= 0·002). Also, continuous analyses (per
2 E%) showed significantly lower risk of CHD with higher
intake of SFA (HR 0·78, 95 % CI 0·66, 0·92), after adjusting
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Table 1 Baseline characteristics by quartiles of carbohydrate intake (energy percentage (E%)), The Hordaland Health Study*





















Carbohydrates (E%) 49 46, 53 43 40, 44 48 47, 48 51 50, 52 56 54, 58 <0·001
Carbohydrates (g/d per 1000
kcal)
123 114, 132 107 101, 110 119 116, 121 127 125, 129 139 135, 145 <0·001
Participants (n) 2995 749 749 748 749
Age (years) 48 47, 48 48 47, 48 48 47, 48 48 47, 48 48 47, 48 0·822
Men 1282 42·8 348 46·5 332 44·3 320 42·8 282 37·7 0·001
College and/or university
education
1138 38·3 253 34·0 308 41·3 286 38·4 291 39·5 0·059
Family history of infarction 1186 40·9 301 42·0 283 39·0 297 41·0 305 41·7 0·952
Smoking habits <0·001
Previous smokers 915 31·2 218 29·5 225 30·4 240 32·9 232 32·1
Current smokers 982 33·5 337 45·7 268 36·2 203 27·8 174 24·1
Physical activity <0·001
None 745 25·9 218 30·0 188 26·0 174 24·1 165 23·3
<1 h/week 813 28·2 220 30·2 225 31·2 189 26·2 179 25·3
1–2 h/week 908 31·5 189 26·0 232 32·1 246 34·1 241 34·0
≥3 h/week 415 14·4 101 13·9 77 10·7 113 15·7 124 17·5
Hypertension 708 23·7 171 22·9 184 24·6 178 23·8 175 23·4 0·886
Glucose intolerance 0·050
Pre-diabetes 66 2·2 21 2·8 19 2·6 14 1·9 12 1·6
Diabetes 27 0·9 9 1·2 8 1·1 3 0·4 7 0·9
Casual glucose (mmol/l)‡ 5·01 4·64, 5·49 5·04 4·69, 5·50 5·02 4·65, 5·53 5·01 4·64, 5·45 4·96 4·60, 5·44 0·094
BMI (kg/m2) 24·9 22·8, 27·4 25·0 23·0, 27·5 24·7 22·7, 27·2 24·9 22·7, 27·4 24·9 22·8, 27·4 0·410
Waist circumference (cm) 85·0 77·0, 94·0 86·0 77·0, 95·0 85·0 76·0, 93·0 85·0 77·0, 93·0 84·0 76·0, 93·0 0·003
Cholesterol (mmol/l)‡ 5·65 5·06, 6·30 5·72 5·13, 6·45 5·66 5·04, 6·28 5·64 5·04, 6·27 5·57 5·01, 6·22 0·001
LDL-cholesterol (mmol/l)‡ 3·57 3·01, 4·17 3·60 3·03, 4·27 3·58 3·01, 4·15 3·57 3·02, 4·18 3·51 2·96, 4·09 0·010
HDL-cholesterol (mmol/l)‡ 1·28 1·06, 1·53 1·29 1·08, 1·54 1·29 1·05, 1·55 1·28 1·06, 1·53 1·26 1·03, 1·51 0·017
TAG (mmol/l)‡ 1·40 1·01, 2·04 1·42 1·01, 2·1 1·39 1·00, 1·94 1·37 1·00, 2·01 1·41 1·02, 2·10 0·933
Medications for
Diabetes 14 0·5 4 0·5 4 0·5 2 0·3 4 0·5 0·842
Hypertension 134 4·5 29 3·9 40 5·3 33 4·4 32 4·3 0·879
Hypercholesterolemia 50 1·7 19 2·5 7 0·9 12 1·6 12 1·6 0·262
Dietary intake
SFA (E%) 13 11, 14 14 13, 16 13 12, 14 12 11, 13 11 9, 12 <0·001
Total fat (E%) 33 29, 36 38 35, 41 34 32, 36 31 30, 33 27 25, 29 <0·001
Protein (E%) 16 14, 17 17 15, 18 16 15, 17 16 14, 17 15 14, 16 <0·001
Alcohol (E%) 1 0, 3 2 1, 4 1 0, 3 1 0, 2 1 0, 2 <0·001
Cholesterol (mg/d per
1000 kcal)
130 110, 152 152 131, 176 137 119, 156 126 111, 142 107 91, 125 <0·001
Fibre (g/d per 1000 kcal) 11 10, 13 10 9, 11 11 10, 12 12 10, 14 13 11, 16 <0·001



















































Intake of food items
Cakes
g/d per 1000 kcal 10 5, 17 8 3, 14 11 5, 18 11 6, 18 10 5, 16 0·001
E% carbohydrates 1·5 0·7, 2·6 1·2 0·5, 2·1 1·6 0·7, 2·6 1·6 0·9, 2·8 1·5 0·7, 2·6 <0·001
Snacks
g/d per 1000 kcal 2 1, 5 3 1, 6 2 1, 5 2 1, 4 1 0, 4 <0·001
E% carbohydrates 0·3 0·1, 0·7 0·4 0·1, 0·8 0·3 0·1, 0·7 0·3 0·1, 0·7 0·2 0, 0·6 <0·001
Soft drinks with sugar
g/d per 1000 kcal 25 0, 65 18 0, 43 28 2, 68 27 2, 63 34 1, 86 <0·001
E% carbohydrates 1·0 0, 2·6 0·7 0, 1·7 1·1 0·1, 2·8 1·1 0·1, 2·6 1·4 0·0, 3·6 <0·001
Fresh fruit and berries
g/d per 1000 kcal 62 35, 98 43 24, 71 59 35, 91 66 42, 104 85 48, 139 <0·001
E% carbohydrates 3·3 1·9, 5·3 2·3 1·3, 3·7 3·2 1·9, 4·8 3·6 2·2, 5·6 4·5 2·6, 7·5 <0·001
Juice
g/d per 1000 kcal 20 2, 49 12 0, 32 21 4, 48 26 6, 58 23 2, 63 <0·001
E% carbohydrates 0·8 0·1, 2·0 0·5 0, 1·3 0·8 0·2, 1·9 1·0 0·2, 2·3 0·9 0·1, 2·5 <0·001
Conserved fruit and berries
g/d per 1000 kcal 13 3, 25 7 1, 18 13 4, 24 16 6, 28 17 5, 32 <0·001
E% carbohydrates 2·3 0·4, 4·8 1·0 0, 3·4 2·3 0·5, 4·4 2·9 0·9, 5·3 3·1 0·7, 6·1 <0·001
Bread
g/d per 1000 kcal 85 69, 105 77 60, 93 83 67, 99 88 72, 108 98 78, 120 <0·001
E% carbohydrates 16·4 13·2, 20·1 14·7 11·7, 17·8 15·8 13·0, 18·9 16·8 13·8, 20·7 18·7 14·8, 22·9 <0·001
Rice, pasta, flour, cereals
g/d per 1000 kcal 19 12, 28 16 10, 23 19 12, 26 20 13, 29 21 13, 33 <0·001
E% carbohydrates 3·7 2·3, 5·9 3·0 2·0, 4·6 3·6 2·3, 5·5 4·1 2·6, 6·4 4·5 2·6, 7·3 <0·001
Potatoes
g/d per 1000 kcal 48 32, 67 47 30, 63 47 33, 64 48 31, 67 52 33, 71 <0·001
E% carbohydrates 4·1 2·7, 5·6 4·0 2·6, 5·4 4·1 2·9, 5·5 4·1 2·7, 5·6 4·3 2·8, 5·8 <0·001
Vegetables
g/d per 1000 kcal 85 54, 131 82 53, 122 85 55, 129 88 57, 132 87 52, 136 0·136
E% carbohydrates 2·2 1·5, 3·2 2·2 1·4, 3·1 2·2 1·5, 3·2 2·3 1·5, 3·2 2·3 1·4, 3·3 0·038
Q, quartile.
*Values are presented as n and % and median (25th, 75th percentiles) for categorical and continuous variables, respectively.
†Logistic regression for categorical variables with two categories, ordered logistic regression whenmore than two categories and linear regression for continuous variables wheremedian intake as E%within each quartile group was used as the
independent variable in the analyses.
‡In serum.
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for age, sex, energy intake, smoking habits and physical
activity. Further adjustments for intermediate factors,
relevant medications and potential confounders did not
materially influence the association (see online supple-
mentary material, Supplemental Table S1).
Figure 1(b) illustrates lower risk of CHD with a higher
intake of SFA until an intake of about 13 E%, after which
the curve levelled off, after adjustment for model 2
variables.
When stratifying on smoking habits, there was a ten-
dency of lower risk of CHD with higher intake of SFA in
all groups, but less so among current smokers (see online
supplementary material, Supplemental Table S2).
When examining the association between SFA from
various food items, we found that only SFA from cheese
was significantly associated with a lower risk of CHD
(Table 3). The median intake of SFA from cheese ranged
from 0·5 E% (Q1) to 4·1 E% (Q4). After adjustments for
age, sex, energy intake, physical activity and smoking hab-
its (model 2), SFA from cheese was significantly associated
with lower risk of CHD in the quartile analyses (HRQ4 v. Q1
0·44, 95 % CI 0·24, 0·83, Ptrend= 0·006). Results from the
evaluation of SFA from cheese as a continuous variable
(per 1 E%) were similar.
We further evaluated the association between SFA and
CHD after excluding the SFA contribution from cheese, and
in the quartile analyses, we found that intake of SFA after
exclusion of cheese was associated with lower risk of
CHD (HRQ4 v. Q1 0·58, 95 % CI 0·34, 0·98, Ptrend= 0·030),
after adjustment for age, sex, energy intake, physical activity
and smoking habits (model 2, Table 3). Results from the con-
tinuous analyses were in the same direction as the quartile
analyses. Upon further evaluation (Fig. 1(c)), we observed
deviations from linearity in the association between SFA
intake and CHD risk after excluding SFA from cheese.
Higher intake of total carbohydrates correlated signifi-
cantly with lower intake of SFA (ρ = −0·6, P< 0·001) and
lower intake of total fat (ρ = −0·8, P< 0·001). Results from
the theoretical substitution analyses are shown in Fig. 2.
Substitution of 5 % of total energy intake from carbohy-
drates with SFA was associated with a 26 % lower risk of
CHD (model 2 HR 0·74, 95 % CI 0·40, 1·36), although not
statistically significant. A substitution of carbohydrates with
total fat was also associated with lower risk of CHD (model
2 HR 0·75, 95 % CI 0·62, 0·90). To further evaluate whether
substitution analyses of carbohydrates with SFA or with
total fat could be attributed to an underlying beneficial
effect of PUFA, we evaluated results of analyses substitut-
ing carbohydrates with PUFA in which we found a non-
significant association with incident CHD (model 2 HR
1·42, 95 % CI 0·82, 2·47). Further, the substitution of carbo-
hydrates with protein was not associated with the risk of
CHD (model 2 HR 1·09, 95 %CI 0·71, 1·68). When adjusting
for age, sex and energy intake only, results of all substitu-
tion models were in the same direction as in the fully
adjusted model, but were non-significant.
Exclusion of events occurring during the first 2 years of
follow-up yielded no material differences in results.
Discussion
In this community-based study population, high intake of
carbohydrates and low intake of SFA were associated with
higher risk of incident CHD. Intake of SFA from cheese was
significantly associated with lower CHD risk. When evalu-
ating SFA intake after excluding the contribution of SFA
from cheese, the association becameweaker, but remained
significant. Substituting 5 % of total energy intake from car-
bohydrateswith SFA and total fat was associatedwith lower
CHD risk (HR of 0·74 and 0·75, respectively), but was sta-
tistically significant only for total fat. The lack of a sta-
tistically significant finding for SFA may reflect, in part,
the narrower range of SFA intake compared with total fat
and carbohydrate intake.
Carbohydrates reflect a variety of sources including
sucrose, fructose and refined cereals, as well as fibre-rich
whole grains, vegetables and legumes. Refined carbohydrates
and added sugar accounted for a large part of carbohydrate
intake in the Norwegian diet at the time of HUSK baseline
in 1997–1999(5). Even today, few Norwegians comply with
the Nordic nutrition recommendations for fibre intake(31,32).
Per capita sales data indicate that intake of sugar-containing
foods and beverages peaked at the end of the 1990s(5). In
addition, a nationwide diet survey among men and women
16–79 years of age (1997–1999) found that their diet con-
tained inadequate amounts of food products rich in fibre
and that the intake of added sugar was 10 and 9 E% among
men and women, respectively(33). When evaluating baseline
characteristics in this cohort, the intake of fruit and berries,
sugar-sweetened beverages and juice doubled from the low-
est to the highest quartile of carbohydrate intake. In contrast,
intake of rice, pasta, flour and cereals was only modestly
higher and vegetable intake did not differ across quartiles
of total carbohydrate intake. Also,while recommended intake
of fibre is ≥25 g/d in women and ≥35 g/d in men(31), the
median intake of fibre in the total study population was
24 g/d and the median fibre intake in the highest quartile
of carbohydrate intake was 26 g/d. However, FFQ are
affected by systematic errors and do not precisely estimate
dietary intake; therefore, these data should be interpreted
with caution.
Previous cohort studies and meta-analyses have shown
diverse results regarding the association between intake of
carbohydrates and CHD when evaluating total carbohy-
drates. A study of men and women 30–59 years of age
found that carbohydrate intake was associatedwith a lower
CHDmortality risk (RR 0·96, 95 % CI 0·94, 0·99)(34). However,
a large cohort study of individuals aged 35–70 years found
that higher carbohydrate intake was not associated with
the risk of CVD (HR 1·01, 95 % CI 0·88, 1·15) or myocardial
infarction (HR 0·90, 95 % CI 0·73, 1·10)(23). Carbohydrate
intake was not consistently associated with CHD when
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Table 2 Baseline characteristics by quartiles of saturated fat intake (energy percentage (E%)), The Hordaland Health Study*












SFA (E%) 13 11, 14 10 9, 11 12 11, 12 13 13, 14 15 15, 16 <0·001
SFA (g/d per 1000 kcal) 14 12, 16 11 10, 12 13 13, 14 15 14, 15 17 16, 18 <0·001
Participants (n) 2995 749 749 748 749
Age (years) 48 47, 48 48 48, 49 48 47, 48 48 47, 48 48 47, 48 0·151
Men 1282 42·8 327 43·7 349 46·6 318 42·5 288 38·5 0·016
College and/or university education 1138 38·3 291 39·4 281 37·6 290 39·2 276 37·0 0·121
Family history of infarction 1186 40·9 316 43·4 295 40·7 284 39·2 291 40·5 0·227
Smoking habits <0·001
Previous smoker 915 31·2 248 34·2 241 32·9 230 31·2 196 26·7
Current smoker 982 33·5 197 27·2 233 31·8 259 35·1 293 39·9
Physical activity <0·001
None 745 25·9 150 21·0 196 27·3 199 27·4 200 27·7
<1 h/week 813 28·2 192 26·9 168 23·4 221 30·4 232 32·2
1–2 h/week 908 31·5 241 33·7 243 33·8 221 30·4 203 28·2
≥3 h/week 415 14·4 132 18·5 112 15·6 85 11·7 86 11·9
Hypertension 708 23·7 196 26·2 183 24·4 179 24·0 150 20·0 0·006
Glucose intolerance 0·296
Pre-diabetes 66 2·2 15 2·0 17 2·3 11 1·5 23 3·1
Diabetes 27 0·9 6 0·8 6 0·8 9 1·2 6 0·8
Casual glucose (mmol/l)‡ 5·01 4·64, 5·49 5·04 4·66, 5·51 5·01 4·66, 5·47 4·99 4·65, 5·49 4·98 4·60, 5·43 0·400
BMI (kg/m2) 24·9 22·8, 27·4 25·2 23·0, 27·6 25·2 23·0, 27·5 24·8 23·0, 27·4 24·6 22·2, 27·1 0·002
Waist circumference (cm) 85·0 77·0, 94·0 85·0 77·0, 94·0 86·0 78·0, 94·0 85·0 77·0, 93·0 84·0 75·0, 93·0 0·021
Cholesterol (mmol/l)‡ 5·65 5·06, 6·30 5·64 5·06, 6·35 5·61 5·01, 6·26 5·69 5·10, 6·28 5·65 5·08, 6·35 0·729
LDL-cholesterol (mmol/l)‡ 3·57 3·01, 4·17 3·55 2·96, 4·17 3·53 2·99, 4·11 3·58 3·07, 4·17 3·61 3·02, 4·23 0·250
HDL-cholesterol (mmol/l ‡ 1·28 1·06, 1·53 1·29 1·06, 1·53 1·25 1·04, 1·50 1·29 1·07, 1·54 1·32 1·08, 1·57 0·064
TAG (mmol/l)‡ 1·40 1·01, 2·04 1·41 1·04, 2·15 1·47 1·03, 2·08 1·40 1·01, 1·99 1·33 0·95, 1·93 0·005
Medications for
Diabetes 14 0·5 3 0·4 2 0·3 6 0·8 3 0·4 0·704
Hypertension 134 4·5 36 4·8 37 4·9 33 4·4 28 3·7 0·270
Hypercholesterolaemia 50 1·7 20 2·7 11 1·5 14 1·9 5 0·7 0·007
Dietary intake
Carbohydrates (E%) 49 46, 53 54 51, 58 51 48, 53 48 45, 51 45 42, 48 <0·001
Total fat (E%) 33 29, 36 27 25, 29 31 30, 33 34 32, 36 37 35, 40 <0·001
Protein (E%) 16 14, 17 16 14, 17 16 14, 17 16 15, 17 16 14, 17 0·876
Alcohol (E%) 1 0, 3 1 0, 3 1 0, 3 1 0, 3 1 0, 2 <0·001
Cholesterol (mg/d per 1000 kcal) 130 110, 152 115 95, 137 128 110, 149 133 116, 156 143 122, 164 <0·001
Fibre (g/d per 1000 kcal) 11 10, 13 13 11, 16 12 10, 13 11 10, 13 10 8, 11 <0·001
Energy intake (kcal§/d) 2057 1690, 2550 1900 1537, 2335 2093 1731, 2584 2112 1712, 2623 2182 1773, 2584 <0·001


































g/d per 1000 kcal 0 1 0 0 0 1 0 1 0 3 <0·001
E% SFA 0 1 0 0 0 0 0 0 0 1 <0·001
Cheese
g/d per 1000 kcal 13 7, 21 9 4, 14 11 7, 18 15 9, 24 19 11, 32 <0·001
E% SFA 2 1, 3 1 1, 2 2 1, 2 2 1, 3 3 2, 4 <0·001
Margarine
g/d per 1000 kcal 3 2, 8 2 1, 4 3 2, 7 3 2, 9 3 2, 11 <0·001
E% SFA 1 1, 2 1 0, 1 1 1, 2 1 1, 2 1 1, 3 <0·001
Milk and milk products
g/d per 1000 kcal 129 65, 205 131 61, 214 140 71, 213 128 69, 196 119 61, 196 0·031
E% SFA 1 1, 2 1 1, 2 1 1, 2 1 1, 2 2 1, 3 <0·001
Meat and meat products
g/d per 1000 kcal 55 41, 70 49 36, 63 56 43, 70 57 43, 74 57 42, 73 <0·001
E% SFA 2 2, 3 2 2, 3 2 2, 3 2 2, 3 3 2, 3 <0·001
Minced meat products
g/d per 1000 kcal 24 15, 34 20 12, 29 25 16, 33 26 17, 36 26 17, 35 <0·001
E% SFA 1 1, 2 1 1, 1 1 1, 2 1 1, 2 1 1, 2 <0·001
Q, quartile.
*Values are presented as n and % and median and 25th, 75th percentiles for categorical and continuous variables, respectively.
†Logistic regression for categorical variables with two categories, ordered logistic regression when more than two categories and linear regression for continuous variables where median intake as E% within each quartile group was used as the
independent variable in the analyses.
‡In serum.
§To convert kcal to kJ, multiply by 4·184.
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different sources of carbohydrates were considered sepa-
rately. Li et al.(35) found in a cohort study that higher intake
of carbohydrates from whole grains was associated with
lower risk of incident CHD (HR 0·90, 95 % CI 0·83, 0·98),
while carbohydrates from refined starches/added sugars
were positively associated with higher risk of CHD
(HR 1·10, 95 % CI 1·00, 1·21).
Fung et al.(36) studied the association between con-
sumption of sugar-sweetened beverages and the risk of
CHD in the Nurses’ Health Study and found that regular
consumption of sugar-sweetened beverages was associ-
ated with a higher CHD risk. In addition, a meta-analysis
of cohort studies reported that intake of sugar-sweetened
beverages was associated with increased risk of myocardial
Table 3 Associations between macronutrients and risk of incident CHD, The Hordaland Health Study. Mean follow-up time 10·8 years
Intake of macronutrients (range in E%)* n
CHD Model 1† Model 2‡
n % HR 95 % CI HR 95 % CI
Carbohydrates 2995 112
Q1 (21, 45) 749 23 3·1 1 (ref) 1 (ref)
Q2 (45, 49) 749 25 3·3 1·11 0·63, 1·96 1·09 0·60, 1·98
Q3 (49, 53) 748 29 3·9 1·30 0·75, 2·24 1·67 0·96, 2·89
Q4 (53, 74) 749 35 4·7 1·63 0·96, 2·76 2·10 1·22, 3·63
Ptrend§ 0·056 0·003
Continuous (per 2 E%) 2995 112 1·08 1·01, 1·15 1·12 1·05, 1·20
Saturated fat 2995 112
Q1 (4, 11) 749 44 5·9 1 (ref) 1 (ref)
Q2 (11, 13) 749 24 3·2 0·55 0·34, 0·91 0·46 0·27, 0·78
Q3 (13, 14) 748 23 3·1 0·55 0·33, 0·92 0·47 0·28, 0·79
Q4 (14, 25) 749 21 2·8 0·53 0·32, 0·90 0·44 0·26, 0·76
Ptrend§ 0·013 0·002
Continuous (per 2 E%) 2995 112 0·82 0·70, 0·97 0·78 0·66, 0·92
Saturated fat from cheese 2995 112
Q1 (0, 1) 749 45 6·0 1 (ref) 1 (ref)
Q2 (1, 2) 748 28 3·7 0·68 0·43, 1·10 0·78 0·49, 1·27
Q3 (2, 3) 749 25 3·3 0·64 0·39, 1·04 0·60 0·35, 1·03
Q4 (3, 18) 749 14 1·9 0·38 0·21, 0·70 0·44 0·24, 0·83
Ptrend§ 0·002 0·006
Continuous (per 1 E%) 2995 112 0·84 0·74, 0·97 0·87 0·75, 0·99
Saturated fat after excluding saturated fat from cheese 2995 112
Q1 (3, 9) 748 34 4·6 1 (ref) 1 (ref)
Q2 (9, 10) 750 29 3·9 0·85 0·51, 1·39 0·71 0·42, 1·20
Q3 (10, 12) 748 20 2·7 0·56 0·32, 0·98 0·46 0·26, 0·81
Q4 (12, 21) 749 29 3·9 0·81 0·49, 1·34 0·58 0·34, 0·98
Ptrend§ 0·277 0·030
Continuous (per 2 E%) 2995 112 0·94 0·79, 1·12 0·85 0·71, 1·02
E%, energy percentage; CHD, incident CHD; n, number of participants; HR, hazard ratio; Q, quartile.
*Minimum and maximum intake of the macronutrient.
†Cox proportional hazard regression analysis adjusted for age, sex and energy intake.
‡Adjusted in addition for physical activity and smoking habits.




































Intake of SFA after excluding contribution









Fig. 1 Cox proportional hazards regression with penalized splines, The Hordaland Health Study. Distribution of partial hazard (black
line) with 95%CI (shadow) for CHD across the distribution of a) intake of carbohydrates in E%, b) intake of saturated fatty acids (SFA)
in E% and c) intake of SFA after excluding contribution from cheese in E%. The model includes age, sex, energy intake, physical
activity and smoking habits. Intake above the 5thth percentile and below the 95th percentile is included in the figure
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infarction(37). In randomised controlled trials, dietary sugar
intake has been found to increase blood pressure and
serum TAG, TC and LDL-cholesterol(38). While we did
not identify any one particular source of carbohydrates
to contribute to the overall carbohydrate association with
CHD,we did note differences in the quality of carbohydrate
sources between low to high carbohydrate intake quar-
tiles where intake of fibre, vegetables and many carbo-
hydrate sources remained essentially stable, while
bread, sugar-sweetened beverages, juice, and preserved
and fresh fruit and berries increased across the quartiles of
carbohydrate intake. Thereby indicating that increased
carbohydrate intake in the current study population rep-
resented increases in low-fibre and higher sucrose/fruc-
tose carbohydrates.
SFA intake in our study population came primarily from
dairy products, especially cheese. The intake of cheese
more than doubled from the lowest to the highest quartile
of SFA intake, and cheese was also the main contributor to
SFA intake in the highest quartile. As dairy products are
important contributors of SFA, the general recommenda-
tion in Norway has been to reduce the intake of high-fat
dairy products(39). However, studies do not consistently
support that this recommendation would reduce risk of
CHD(40–42). A systematic review and meta-analysis did
not report a statistically significant association between
total dairy intake and CHD (Summary RR 0·91, 95 % CI
0·80, 1·04)(41). Further, the only dairy product significantly
associated with lower CHD risk was cheese (Summary RR
0·82, 95 % CI 0·72, 0·93)(41). In addition, Qin et al.(42)
reported no association between dairy intake and CHD
(RR 0·94, 95 % CI 0·82, 1·07), and CHD risk was lowered
by cheese consumption also in this study (RR 0·84, 95 %
CI 0·71, 1·00).
We found that intake of SFA from cheese was the only
food source associated with a lower risk of CHD. Under-
lying mechanisms for a potential CHD protective effect
of cheese may relate to (i) fermentation which may influ-
ence dairy fat’s contribution to LDL-cholesterol(43) and
(ii) menaquinones (vitamin K2) which comes primarily
from cheese in European diets(44). Geleijnse et al.(45) found
that menaquinone intake was inversely associated with
serum TC and aortic calcification and positively associated
with serum HDL-cholesterol. Menaquinones transported
together with SFA may, therefore, be associated with lower
CHD risk. Also, as most cheeses are not homogenised, they
still contain milk fat globule membranes. Rosqvist et al.(46)
reported that intake of milk fat enclosed by milk fat globule
membranes did not impair the lipoprotein profile when
compared with butter oil. When evaluating the association
between SFA and CHD after excluding the contribution
from cheese, intake of SFA was still associated with lower
risk of CHD. The penalised spline illustrates almost the
same pattern as for total SFA, but with a tendency of higher
risk at higher intakes.
A systematic review and meta-analysis found that when
comparing the highest v. lowest intake of SFA, there was
no association observed between SFA intake and CHD
0
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Fig. 2 Theoretical substitution analyses, illustrating an isocaloric substitution of 5E% from carbohydrates with total fat, saturated fatty
acids (SFA), polyunsaturated fatty acids (PUFA) or protein and its association with CHD. Adjusted for age, sex, energy intake, physi-
cal activity and smoking habits. Mean 10·8 years follow-up of the Hordaland Health Study participants
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(RR 1·03, 95 % CI 0·98, 1·07)(18). Another meta-analysis of
cohort studies found that the highest v. lowest quintile
intake of SFA had a weak association with the risk of
CHD (RR 1·06, 95 % CI 0·95, 1·17)(19). However, the quality
of the documentation was regarded as very low, and in an
analysis not adjusted for cardiovascular risk factors such as
serum cholesterol, there was a significantly higher risk of
CHD mortality comparing the highest v. lowest intake of
SFA (RR 1·20, 95 % CI 1·02, 1·41)(19).
Our results differ from these meta-analyses and likely
reflect that, in the current study population, cheese was
the predominant contributor to SFA, there was a narrow
range of median SFA intake in the four quartiles, and there
was an inverse association between SFA and carbohydrate
intake.
Theoretical substitution analyses
Analysing the effect of one nutrient when considering the
nutrients it substitutes provides another means of under-
standing the observed associations(30). Another study sug-
gested that reducing the intake of carbohydrates from
refined grains and added sugars may produce beneficial
metabolic effects that may decrease the risk of CHD(22).
Jakobsen et al.(21) showed that when substituting 5 E%
from SFA by carbohydrates, there was no association with
fatal CHD (RR 0·96, 95 % CI 0·82, 1·13), but a statistically
significant increase in the overall CHD risk (RR 1·07,
95 % CI 1·01, 1·14). When separately evaluating carbohy-
drates with high and low glycaemic index, only a substitu-
tion of SFA with high glycaemic index carbohydrates was
associated with a higher risk of myocardial infarction
(HR 1·33, 95 % CI 1·08, 1·64)(22). Chen et al.(47) evaluated
the association between dairy fat and CHD in US adults
and found no significant benefit of replacing dairy fat with
the same energy intake from refined starch and added
sugar. However, the substitution of 5 % of energy from
dairy fat by carbohydrates from whole grains was associ-
ated with a significantly lower risk of CHD (RR 0·66,
95 % CI 0·62, 0·70).
The tendency for a lower risk of CHD when replacing
carbohydrates with total fat and SFA may reflect a combi-
nation of the beneficial association observed between
cheese consumption and CHD as well as the deleterious
association between low-fibre carbohydrate intake and
CHD. Total fat and SFA intake in the context of high-cheese
consumption may not be generalisable to total fat and SFA
intake in a low-cheese consumption context.
Strengths and limitations
Strengths of our study include a community-based sample
of men and women with a relatively long follow-up time.
Only sixty participants died due to other reasons until
2009; therefore, there was minimal competing risk from
other causes of death. Linkage to the CVDNOR project
database assured as good as complete follow-up. Also,
we had information on health status,medication use, health
habits and history of CHD at baseline, enabling us to evalu-
ate incident CHD. Further, the FFQ captured the major
sources of carbohydrates and SFA expected in the current
study population, and energy adjustment of the statistical
models is a well-established approach for reducing the bias
related to self-reported dietary data.
Theoretical substitution analyses were performed, mod-
elling the substitution of carbohydrates with PUFA, SFA,
protein and total fat. Another strength is the robustness
of the results which were similar frommodel to model after
various adjustments.
Limitations include the relatively small number of
participants and events limiting stratified analyses and
multivariable adjustments.
Another limitation is the lack of information on possible
changes over time in diet, medications and other risk fac-
tors. Both dietary habits and food products have changed
during the study period, due to the recommendations on
reducing intake of SFA as the source of fat and increasing
intake of whole grains as the source of carbohydrates(31,48).
Intake of cooking oil has tripled from the late 1990s to about
2013, and the consumption of vegetables also increased,
while intake of margarine and sugar-containing food
decreased according to per capita sales data(5).
Blood samples were non-fasting. Since postprandial
TAG remain elevated for several hours, and the
Friedewald equation, used for the calculation of LDL-
cholesterol, assumes fasting TAG values, LDL-cholesterol
may be underestimated(49). Also, most reference values for
serum lipids and glucose are established on fasting blood
specimen.
Further, a common problem with FFQ is systematic
under- or overreporting of nutrient and energy intake, limit-
ing the estimation of absolute intake. However, the FFQ is
well suited to rank participants by dietary intake for evalu-
ation of associations with health endpoints(50). Given that
FFQ are not optimal for determining absolute nutrient
intake, caution is required in the interpretation of the theo-
retical substitution models(51).
There may also be other limitations. A large proportion
(75 %) of the participants reported zero intake of butter,
likely reflecting underreporting. Also, we did not have
extensive information on carbohydrate quality particularly
for bread due to lack of historical food recipes, lack of
food label details and type of carbohydrate content for
the recipes from the dietary database at the end of
the 1990s.
Nevertheless, whenwe adjusted for estimated fibre from
bread, vegetables and fruit intake, total carbohydrate intake
remained a statistically significant predictor of higher CHD
risk. Another limitation of the current study is that the
results cannot be generalisable to populations with a
greater range in carbohydrate or SFA intake. In the current
study, the intake of SFA varied from 4 to 25 E% and the
intake of carbohydrates varied from 21 to 74 E% resulting
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in a narrower range of intake when we evaluated the
median intake between the lowest and highest quartiles
(i.e., 10–15 E% for SFA and 43–56 E% for carbohydrates),
precluding our ability to generalise to lower and higher
intake values. The current study can therefore not be com-
pared with previous studies that have shown higher all-
cause and cause-specific mortality associated with much
lower carbohydrate intakes than our study population(52,53).
Finally, the available data were not appropriate for studying
unsaturated fat, given the changing trans-fatty acid compo-
sition of unsaturated fat during the study period.
While reverse causation is a general concern in observa-
tional studies of dietary habits and disease outcomes, we
noted a similar percentage of participants with a family
history of CHD and similar baseline BMI values across
quartiles of carbohydrate and SFA intake. Further, adjusting
for family history of CHD andBMI did not alter our findings.
Although we performed multivariable analyses, residual
confounding may still be present.
Lastly, it is of note that at the end of follow-up, partici-
pants’ age was generally lower than the mean age of acute
myocardial infarction in Norway which is 73·8 years for
men and 79·1 years for women(54). Thus, our findings may
reflect mechanisms involved in early-onset CHD and may
not necessarily be generalisable to older populations.
Conclusion
The focus of the current study was to evaluate the impor-
tance of the interplay between SFA and total carbohydrates,
including SFA sources, when evaluating the association
between SFA and CHD. A high intake of carbohydrates,
reflecting low-fibre and relatively higher sucrose/fructose
dietary sources, and a low intake of SFAwere associated with
higher CHD risk in the current study population. Substituting
carbohydrates with total fat was associated with lower risk.
Also, SFA from cheesewas associatedwith lower risk of CHD.
Further research evaluating potential benefits of dairy
products and their nutritional constituents is warranted.
Also, there is a need to clarify the relative health trade-offs
between replacing carbohydrate intake with fat intake in
study populations with diverse dietary habits and a wider
range in carbohydrate and SFA intakes. In addition, results
of our study suggest that dietary guidelines development
and their communication to the public, especially regard-
ing reductions in certain foods and nutrients, need to con-
sider the potential health impact of alternative sources of
energy.
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